Among the women with NAFLD, ORs of LSMM for lean NAFLD were maintained after stepwise adjustment for age, DM, hypertension, and WC (Model 1: OR, 4.9; 95% CI, 3.53–6.91; p < 0.001); for presence of IR and CRP (Model 2: OR, 4.96; 95% CI, 3.57–7.01; p < 0.001); and for serum alanine aminotransferase, gamma-glutamyl transferase, triglyceride levels, and platelet count (Model 3: OR, 5.24; 95% CI, 3.78–7.57; p < 0.001) (Table 4). The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.